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Abstract
Background: We sought to understand the main ethical considerations when conducting clinical trials in the
prehospital ambulance based setting.
Methods: A systematic review of the literature on randomised controlled trials in ambulance settings was undertaken.
A search of eight databases identified published studies involving recruitment of ambulance service users. Four
independent authors undertook abstract and full-text reviews to determine eligibility and extract relevant data. The
data extraction concentrated on ethical considerations, with any discussion of ethics being included for further analysis.
The resultant data were combined to form a narrative synthesis.
Results: In all, 56 papers were identified as meeting the inclusion criteria. Issues relating to consent were the most
significant theme identified. Type of consent differed depending on the condition or intervention being studied. The
country in which the research took place did not appear to influence the type of consent, apart from the USA where
exception from consent appeared to be most commonly used. A wide range of terms were used to describe consent.
Conclusions: Consent was the main ethical consideration in published ambulance based research. A range of consent
models were used ranging from informed consent to exception from consent (waiver of consent). Many studies cited
international guidelines as informing their choice of consent model but diverse and sometimes confused terms were
used to describe these models. This suggests that standardisation of consent models and the terminology used to
describe them is warranted.
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Background
Prehospital or ambulance based research is a relatively
new but rapidly developing field. A lack of randomised
controlled trials (RCTs) in the prehospital setting has
meant that most prehospital care relies on extrapolation
from other sources. These are most often in-hospital tri-
als that may face similar pressures such as timeliness of
intervention or distress, but differ in other respects such
as lack of access to resources or trained personnel and
uncertainty of diagnosis [1].
In addition, extrapolation of evidence from in-hospital
settings is not always valid since interventions that may
be seen as the gold standard in hospital may not be fea-
sible or of benefit in patients’ homes or during transport
to hospital [2]. It has been argued that prehospital care
itself is unique and therefore is likely to give rise to a dif-
ferent set of ethical considerations compared to research
in other clinical care settings [3].
Ethical considerations in any research setting are com-
plex and must account for a range of factors often based
on risk/benefit analysis [4]. These ethical considerations
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are based on four basic principles, namely autonomy,
non-maleficence, beneficence and justice [5]. In other
words, people should be informed and free to choose
whether to participate or not, the research should be po-
tentially beneficial or in the participants’ ‘best interests’,
risk of potential harm should be minimised, and studies
should be equitable in recruitment and treatment of par-
ticipants. The nature of a prehospital emergency situ-
ation may mean that the patient is not competent to
make decisions about their best interest. The ability to
achieve informed consent becomes problematic in light
of the time pressures of emergency situations and the
nature of the presenting conditions [3]. Researchers cur-
rently use a variety of models of consent to meet the re-
quirements of legislation and to reflect the nature of the
trial, which can lead to inconsistencies in the use of lan-
guage and application of regulations.
The increasing use of paramedics in research, in par-
ticular in the randomisation and consent of patients to
trials, highlights the need to review best practice in this
area. In an interview study assessing ambulance based
research, 92% of paramedics felt that research was im-
portant, yet only 35% actively took part [1]. Paramedics
that did not participate identified barriers to research in-
cluding the fear that randomisation and consent pro-
cesses would lead to delays in treatment [1]. Therefore,
it is important to understand the issues around gaining
consent for research in the prehospital ambulance set-
ting and to identify ways in which this can be achieved
in practice.
In this study we sought to understand current ethical
practices in prehospital ambulance trials. The aim of the
review was to determine the range of approaches taken
regarding consent models and to compare these ap-
proaches based on factors such as condition being stud-
ied and intervention used.
Methods
The systematic review protocol was registered with
PROSPERO (CRD42016038087). The protocol was de-
signed using the Preferred Reporting Items for Systemat-
ics reviews and Meta-Analysis Protocols checklist
(PRISMA) where possible, although due to the nature of
the review not all of the checklist items were applicable
[6]. We searched the following databases: MEDLINE,
CINAHL, AMED, EBSCOhost, Science Direct, PsycAR-
TICLES, PsycINFO and the Emergency Medicine Jour-
nal using these search terms in the title, abstract or key
words: “emergency medical service*”, “ambulance”, “pre-
hospital” and “emergency” with the additional key words:
“intervention*”, “ethic*”, “procedure”, “ethic* approval”,
“consent”, “confidentiality”, “trial”, “protocol”, and “ran-
domised controlled trial”.
Studies were limited to published or ongoing ran-
domised controlled trials of interventions involving am-
bulance services. More specifically, for studies to be
considered eligible they had to have been conducted
with ambulance service (or equivalent) users, including
either adults or children (‘participants’); use any type of
medical intervention involving ambulance service users
(‘intervention’); explore health outcomes and provide in-
formation on relevant ethics procedures, such as consent
and confidentiality (‘outcomes’); and be RCTs (‘study
design’).
To ensure relevance to current practice and healthcare
settings in developed countries we included studies con-
ducted in the UK, Europe, North America, Australia and
New Zealand between the years 2000 and 2016. Due to
budget constraints papers were limited to those written
in English. Studies were excluded if they did not involve
ambulance service users or if they were case studies or
guidance documents.
A review of titles then identified those most likely to
be relevant and removed duplicates. Critical Appraisal
Skills Programme (CASP) analysis was performed on the
remaining papers to assess risk of bias and study quality
[7]. CASP analysis uses a series of standard questions to
determine if papers fulfil the requirements of the overall
review question and in this case did not result in any pa-
pers being excluded [7]. Finally, a more detailed review
of the abstracts was undertaken by 3 independent re-
viewers (DL, MD and JPA) resulting in 56 papers being
put forward for full text review and data extraction. The
PRISMA flowchart (Fig. 1) illustrates this process.
Data extraction was undertaken by four reviewers
using the following headings: study design (RCT or clus-
ter RCT), country, condition (disease or injury), inter-
vention, blinding, participant details (age, gender and
ethnicity), control group, inclusion criteria, exclusion
criteria and general ethics (including any discussion of
ethics from all sections of the paper). One reviewer (SA)
extracted data from all 56 papers, while the remaining
reviewers (DL, MD and JPA) completed extraction on 18
or 19 papers each. The results of the data extraction
were combined to ensure that all relevant information
was captured.
Once data extraction was completed, narrative analysis
was used to synthesise the data, determine any gaps or
inconsistencies and to highlight any issues to be ad-
dressed. The data were analysed using MS Excel for
fields containing empirical or short format data. For
fields containing large passages of text namely inclusion
and exclusion criteria, and general ethics information
the text was combined and analysed to identify themes
supported by NVivo 10. These themes were then
assessed to determine whether any relationships could
be identified between them.
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Results
The main characteristics of the 56 papers included in the
review (Additional file 1), namely country, condition and
intervention, are summarised in Figs. 2, 3 and 4. English-
speaking countries were the most represented in the
papers but this was not surprising given the language li-
mitations of the review. There were also a high number of
multicentre papers (12, 21.4%), where research had been
undertaken in more than one country. Some studies in-
volved neighbouring countries (for example USA and
Canada or Germany and Netherlands) whilst others in-
cluded a wide range of centres; one study had 12 research
centres across Europe, North America, Australia and
North Africa [8] (Fig. 2). For the multicentre papers the
individual countries are listed in full in Additional file 1.
The studies analysed were mostly emergency situa-
tions, with cardiovascular conditions (28 studies, 49.4%)
such as cardiac arrest occurring most frequently,
followed by stroke (7 studies, 12.5%) and lower risk in-
juries and illnesses (Fig. 3). Interventions fell broadly
into four categories (Fig. 4). Firstly, drug trials (24 stud-
ies, 42.9%) usually involved the early administration of
drugs normally given on arrival at hospital, comparisons
of two routinely used drugs or novel agents, for ex-
ample 100% oxygen to prevent motion sickness during
transport. Secondly, device trials (12 studies, 21.4%)
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included comparison of different airways devices or the
use of automated chest compression units in comparison
to manual chest compressions. Thirdly, alternative path-
way trials (10 studies, 17.9%) sought to relieve the pres-
sures on emergency departments (ED) by routing
patients either to community care or directly to in hos-
pital treatment, bypassing the ED. Finally, alternative
process trials (10 studies, 17.9%) assessed the use of dif-
ferent procedures in the ambulance setting, for example
the use of CPR prior to defibrillation.
The data pertaining to ethical considerations com-
prised larger pieces of text and so were coded and ana-
lysed using NVivo 10. We classified the coded data into
three groups (‘consent issues’, ‘approval issues’ and
‘other’), which highlighted the main themes for further
analysis.
All of the papers reviewed discussed methods used to
gain consent to some degree. Approval issues included
discussion of ethics committee approvals and in some
cases the regulations that were adhered to as part of the
ethics approval, although reporting of this was inconsist-
ent and not all papers included this information (34 of
56). The ‘other’ group contained the smallest number of
papers (11 of 56) and covered various topics. For ex-
ample, one paper discussed the refusal of a study site to
participate, another the impact of media reports on the
project and a third highlighted cost implications. Con-
sent appeared to be the paramount consideration in the
reporting of prehospital research and therefore this area
was subject to further analysis.
In order to produce a narrative analysis of the data,
comparisons were made between the type of consent
Fig. 2 Occurrence of each country as a percentage of the total (N = 56)
Fig. 3 Occurrence of each condition as a percentage of the total (N = 56)
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used and the country in which the study took place, the
condition under investigation and the intervention used.
The type of consent will have been influenced by the
legislation and regulations of the country in question, al-
though several papers did refer to international guide-
lines such as the Declaration of Helsinki or the Good
Clinical Practice (GCP) guidelines [9, 10](Table 1).
Many of the studies used more than one method for
gaining consent, which is reflected in Table 1. The
widest range of consent types used was in the United
Kingdom (UK). This may reflect the number of UK
studies reviewed, but also that UK trials often use mul-
tiple consent models such as informed consent and a
variety of proxy consent processes (relatives as proxies
being the most common) [11]. (The term proxy consent
in this paper refers to gaining either legal consent or
opinion from a person other than the participant,
sometimes referred to as surrogate consent.)
Informed consent was the most widely used form of
consent across the different countries. In the USA ex-
ception from informed consent (waiver of consent) was
most common and was used in all but one of the stud-
ies, in which paramedics consented to their own partici-
pation. In other countries where waiver of consent was
used this was often coupled with some form of add-
itional consent, such as consent for follow-up data col-
lection and the opportunity for participants to withdraw
their involvement [12–14]. Multicentre papers tended to
use a single form of consent, either waiver of consent or
informed consent, with only two of the twelve multicen-
tre papers using more than one type of consent [15].
This suggests ethical regulations and in particular con-
sent requirements are not barriers for international trials,
and that the differences seen in UK trials could be due to
other factors such as the conditions being studied. Ana-
lysis showed that the UK studies included four stroke
Fig. 4 Occurrence of each intervention as a percentage of the total (N = 56)
Table 1 A comparison of type of consent obtained and the country where the research took place. (N = number of trials. Note
some trials used more than one type of consent)
Type of Consent Multicentre
(N = 12)
UK
(N = 12)
Australia
(N = 12)
USA
(N = 4)
Canada
(N = 4)
Germany
(N = 4)
France
(N = 2)
Sweden
(N = 2)
Austria
(N = 1)
New Zealand
(N = 1)
Finland
(N = 1)
Norway
(N = 1)
Total
Waived Consent 4 3 6 3 3 1 1 – – – – 1 22
Informed Consent 7 2 2 – 1 3 1 2 – 1 – – 19
Relative Proxy 1 4 1 – 1 – – 2 – 1 1 – 11
Delayed Consent 1 1 3 – – 2 1 1 – – – – 9
Consent for Follow Up 1 2 1 – – – 1 – – – – – 5
Verbal Consent – 2 1 – – – 1 – – – – – 4
Paramedic Proxy – 2 – – – – – – – – – – 2
Retrospective Consent – 1 1 – – – – – – – – – 2
Paramedic Consented – – – 1 – – – – – – – – 1
Opt Out – 1 – – – – – – – – – – 1
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trials, all of which used multiple consent models. The
multicentre trials predominately involved cardiovascu-
lar disorders such as myocardial infarction or cardiac
arrest, participants in these trials may have been more
likely to uniformly lack capacity therefore simplifying
the consent process.
A comparison of type of consent with the condition
being studied showed that where patients lacked cap-
acity for example due to cardiac arrest, waiver of consent
was the most commonly used model (Table 2). In pa-
tients who survived the initial illness, additional consent
for follow-up data collection was often used [14, 16, 17].
In these cases, there was also commonly provision for
relative proxy consent or delayed consent whereby pa-
tients were asked to complete a consent form when they
recovered capacity [18–20]. Trials involving stroke pa-
tients tended to have the most varied consent models
and usually included more than one type of consent,
reflecting the varying severity of strokes, and potential
loss of capacity, and the complex nature of the condi-
tion. This is reflected in Table 2 as, whilst there were
only seven stroke trials reported, stroke accounted for
18 models of consent. The majority of trials where pa-
tients were likely to have capacity, even in an emergency
situation, asked patients to provide written informed
consent in the prehospital setting (usually in the ambu-
lance). Several studies highlighted that even when a pa-
tient was conscious factors such as pain could influence
their capacity to give informed consent [21, 22].
Analysis of consent type compared with intervention
found that most trials involving drug treatments re-
quired informed consent or some form of proxy consent
(Table 3). Where waiver of consent was used this was
often accompanied by consent for follow-up data usage
in survivors [11]. Trials evaluating alternative pathways
also tended to use written informed consent in the am-
bulance. Patients in these trials were more likely to have
capacity and most would not have required transpor-
tation to hospital, and therefore informed consent was
obtainable [23]. Two papers in this group used what was
termed retrospective consent to describe a process
whereby gaining consent was delayed until after the
initial incident had passed [21, 24]. Device trials most
frequently used waiver of consent, the devices used in
these trials being mainly airway or automated chest
compression devices [12, 25]. In both cases the illnesses
necessitating the use of these devices would render the
participants incapable of giving informed consent
themselves.
Discussion
This review analysed 56 studies undertaken in the pre-
hospital setting by paramedics (or equivalent) for a range
of conditions and interventions. Consent was the
paramount consideration when reporting ethical issues
around clinical trials undertaken in the prehospital am-
bulance based setting. Analysis of the methods for
obtaining consent showed relationships between the type
of consent and both the condition and the intervention
being assessed.
For conditions or interventions where participants
were more likely to lack capacity, waiver of consent,
proxy consent (usually from a relative) or delayed con-
sent models were used. The review also analysed the
type of consent in relation to the country in which the
research took place. From the data, country did not
appear to have a direct impact on the type of consent
model used, with the exception of the United States
(USA), where exception from consent (waiver of con-
sent) was the model of choice. US Food and Drug
Administration (FDA) regulation 21CFR50.24 clearly
sets out the requirements for emergency research and
the use of exception from consent would appear to be
the accepted norm [26].
Many of the studies reviewed contained statements
regarding ethical approvals, with several including state-
ments regarding compliance with international guidance,
in particular the Declaration of Helsinki or Good Clin-
ical Practice (GCP) guidelines [9, 10]. Most of the stud-
ies from the USA mentioned compliance with the FDA
21CFR50.24 regulations, which provide criteria allowing
exception from informed consent [26]. All of these regu-
lations or guidelines set standards for obtaining consent
in medical research in a hierarchy of preference where
written informed consent from the participant is the
favoured method, followed by consent from a personal
or legal representative (proxy consent).
Most legislation includes emergency provisions allow-
ing participants to be recruited to the study provided
they (or their representative) are informed at the earliest
opportunity and they are given the option to withdraw
from the study. Whilst several trials did indicate the
number of participants withdrawing from the study,
most did not, nor did they indicate that participants
were given this option [12, 27, 28]. This is an area where
reporting of ethical considerations in clinical trials could
be more explicit.
Terminology relating to consent is an area that needs
greater consistency, particularly where emergency ex-
ception or waiver of consent is used. Whilst many papers
did use the terms exception from or waiver of consent, in
line with guidance documents, several used other terms
such as delayed or retrospective consent [21, 23, 24, 29].
The term delayed consent does not appear in any of the
guidance documents, but in effect describes the emer-
gency exception from consent model, whereby consent
must be sought as soon as possible either from the parti-
cipant or their representative. Retrospective consent in
Armstrong et al. BMC Medical Research Methodology  (2017) 17:142 Page 6 of 10
Ta
b
le
2
C
om
pa
ris
on
of
ty
pe
of
co
ns
en
t
w
ith
th
e
co
nd
iti
on
be
in
g
st
ud
ie
d
(N
=
nu
m
be
r
of
tr
ia
ls
.N
ot
e
so
m
e
tr
ia
ls
us
ed
m
or
e
th
an
on
e
ty
pe
of
co
ns
en
t)
Ty
pe
of
C
on
se
nt
C
ar
di
ac
A
rr
es
t
(N
=
19
)
ST
EM
I
(N
=
9)
St
ro
ke
(N
=
7)
A
irw
ay
s
Is
su
es
(N
=
3)
Pa
in
(N
=
3)
O
th
er
H
ea
rt
C
on
di
tio
ns
(N
=
2)
Lo
w
Ri
sk
In
ju
ry
(N
=
2)
Fr
ac
tu
re
s
(N
=
2)
Fa
lls
(N
=
2)
Pe
lv
ic
Pa
in
(N
=
1)
H
yp
ov
ol
ae
m
ic
Sh
oc
k
(N
=
1)
H
ea
d
In
ju
ry
(N
=
1)
Se
da
tio
n
(N
=
1)
H
yp
og
ly
ca
em
ia
(N
=
1)
M
ot
io
n
Si
ck
ne
ss
(N
=
1)
El
de
rly
Pa
tie
nt
s
(N
=
1)
To
ta
l
W
ai
ve
d
C
on
se
nt
13
–
1
2
1
2
–
–
–
–
1
1
1
–
–
–
22
In
fo
rm
ed
C
on
se
nt
–
7
5
–
1
–
1
2
–
1
–
–
–
–
1
1
19
D
el
ay
ed
C
on
se
nt
4
2
1
–
–
–
–
–
–
–
–
–
–
1
–
–
8
Re
la
tiv
e
Pr
ox
y
3
1
4
1
–
–
–
1
–
–
–
–
–
–
–
1
11
Pa
ra
m
ed
ic
Pr
ox
y
–
–
2
–
–
–
–
–
–
–
–
–
–
–
–
–
2
C
on
se
nt
fo
r
Fo
llo
w
U
p
5
–
3
–
1
1
–
–
–
–
–
–
–
–
–
–
10
Ve
rb
al
C
on
se
nt
–
–
2
–
1
–
1
1
–
–
–
–
–
–
–
–
5
Re
tr
os
pe
ct
iv
e
C
on
se
nt
–
–
–
–
–
–
–
–
1
–
–
1
–
–
–
–
2
Pa
ra
m
ed
ic
C
on
se
nt
ed
–
–
–
1
–
–
–
–
–
–
–
–
–
–
–
–
1
O
pt
O
ut
–
–
–
–
–
–
–
–
1
–
–
–
–
–
–
–
1
Armstrong et al. BMC Medical Research Methodology  (2017) 17:142 Page 7 of 10
these studies was used in the same way as a means of de-
scribing the process of emergency exception and later
consent, but the use of this term could be problematic.
Previously the term ‘retrospective consent’ has been
referred to in psychology research as consent that is
sought after the intervention in order to correct a deliber-
ate deception on the part of the researcher. In psychology
research deliberate deception may be necessary for the in-
tegrity of the research and the term retrospective consent
is used in those circumstances where the researcher later
informs the participant of the true nature of the research
and gains consent to replace any consent given before the
intervention [30]. Since deliberate misrepresentation
would not occur in clinical trials in the prehospital envi-
ronment, the use of the term retrospective consent may
be confusing.
The use of terminology was not specific to the country
in which the research took place and terms for type of
consent were used interchangeably across all countries,
conditions and interventions. This supports the need for
standardisation of terminology for consent in research
and subsequent publications.
Further consideration should also be given to the na-
ture of informed consent. The Declaration of Helsinki
and the GCP guidelines state that exception from con-
sent should only be used where there is a medical emer-
gency where timeliness of the intervention means that it
cannot be delayed in order to gain consent from a legal
representative [9, 10]. In general this is limited to condi-
tions such as cardiac arrest or stroke where the outcome
for the patient could be affected by a delay in treatment.
This means that, when a patient has called an ambu-
lance in a situation not technically classed as a medical
emergency, any research intervention will require con-
sent from the patient or a surrogate. Several papers dis-
cussed the issue of gaining consent in the prehospital
setting when a participant has called an ambulance in a
situation not classed as a medical emergency [21, 22].
Situations that necessitate calling an ambulance are by
their nature stressful, not only to potential participants
but also to their relatives, who might act as their repre-
sentatives. This suggests that consent gained under
these circumstances may not be a true reflection of the
participant’s wishes if they or their surrogate had more
time and a less stressful situation in which to consider
taking part.
Research in the prehospital setting may therefore re-
quire a different approach to consent, whether this is
through a broadening of exception from consent to in-
clude situations not classed as medical emergencies or
through a different approach entirely, such as assent.
The Declaration of Helsinki does briefly discuss the use
of assent for individuals who cannot give informed con-
sent for inclusion in research but do have the capacity to
agree to treatment. This would then be coupled with in-
formed consent from the participant or from their legal
representative as soon as possible. This is an aspect that
needs further exploration, discussion and agreement by
the wider research community.
Although this review has focussed on consent because
of the nature of the review question and process, there
are a range of other ethical issues raised by prehospital
trials. Aspects such as patient perceptions and practi-
tioner views of prehospital research have begun to be ex-
plored in previous studies [31]; these and other ethical
concerns of ambulance trials such as the balance of risk
and benefits or equity of participation should be ad-
dressed in future studies in order to guide future re-
search design [32].
Limitations
The search strategy was comprehensive, however we ac-
knowledge that because it was limited to available data-
bases and papers published in the English language (due
Table 3 Comparison of type of consent with the type of intervention being studied. (N = number of trials. Note some trials used
more than one type of consent)
Type Of Consent Drug V Placebo
(N = 24)
Alternative Pathway
V Normal Care (N = 10)
Alternative Process
V Normal Care (N = 10)
Device Trial V Placebo
or Normal Care (N = 12)
Total
Waived Consent 8 2 3 9 22
Informed Consent 11 6 1 1 19
Delayed Consent 2 1 4 1 8
Relative Proxy 4 2 3 2 11
Paramedic Proxy 2 – – – 2
Consent For Follow Up 6 – 1 3 10
Verbal Consent 5 – – – 5
Retrospective Consent – 2 – – 2
Paramedic Consented – – – 1 1
Opt Out – 1 – – 1
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to time and budget constraints), all relevant papers may
not have been identified. Our intention with this paper
was to identify ethical considerations in clinical trials
undertaken in ambulance settings through the review of
published RCT papers and as such the analysis was lim-
ited to only those ethical considerations discussed in the
resultant papers. However, it may be that ethical issues
occurred during these trials that were not reported in
the resultant publications. Moreover, it may be that add-
itional ethical considerations (beyond consent) are re-
ported elsewhere, for example in discussion or case
study articles that focus on prehospital ambulance based
research more generally.
Conclusion
Prehospital ambulance research is a developing field that
aims to expand the evidence base with the aims of im-
proving outcomes for patients and implementing cost-
effective approaches for healthcare provision. Prehospital
care is unique due to the environmental and time pres-
sures of delivering clinical interventions in this setting,
which will impact on ethical considerations. This sys-
tematic review of the literature found that the ability to
obtain consent was the overarching ethical conside-
ration. The stressful nature of ambulance calls leads to
questions regarding the ability to obtain written in-
formed consent. Whether alternative methods such as
wider use of emergency exception from consent, or
assent coupled with consent to include follow-up data
collection should be standard for this type of research is
unclear. The use of terminology to describe consent
models was also highly varied and standardisation of ter-
minology would be beneficial for clarity of consent (for
both participants and investigators) and ethical consider-
ations in prehospital clinical trials.
Additional file
Additional file 1: Full reference list and basic summary of data collected
from the papers reviewed. (DOCX 36 kb)
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